"Occult Blood" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood.
Descriptor ID |
D009780
|
MeSH Number(s) |
E01.370.225.925 E05.200.925
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Occult Blood".
Below are MeSH descriptors whose meaning is more specific than "Occult Blood".
This graph shows the total number of publications written about "Occult Blood" by people in this website by year, and whether "Occult Blood" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 |
1997 | 2 | 0 | 2 |
1999 | 0 | 1 | 1 |
2000 | 1 | 2 | 3 |
2002 | 0 | 2 | 2 |
2005 | 1 | 1 | 2 |
2006 | 1 | 4 | 5 |
2007 | 0 | 1 | 1 |
2008 | 1 | 0 | 1 |
2009 | 2 | 0 | 2 |
2010 | 0 | 1 | 1 |
2013 | 1 | 1 | 2 |
2014 | 0 | 3 | 3 |
2015 | 1 | 1 | 2 |
2017 | 2 | 0 | 2 |
2018 | 0 | 4 | 4 |
2019 | 1 | 1 | 2 |
2020 | 0 | 2 | 2 |
2021 | 1 | 4 | 5 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Occult Blood" by people in Profiles.
-
An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles. Gut. 2023 10; 72(10):1904-1918.
-
Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial. Lancet Gastroenterol Hepatol. 2022 06; 7(6):513-521.
-
Combining the quantitative faecal immunochemical test and full blood count reliably rules out colorectal cancer in a symptomatic patient referral pathway. Int J Colorectal Dis. 2022 Feb; 37(2):457-466.
-
The role of faecal calprotectin in the identification of colorectal neoplasia in patients attending for screening colonoscopy. Colorectal Dis. 2022 02; 24(2):188-196.
-
Low Prevalence of Screen-Detected Colorectal Cancer in an Average-Risk Population: The New Normal. Clin Gastroenterol Hepatol. 2022 Nov; 20(11):2650-2652.e1.
-
Colorectal cancer screening in African Americans: are we following the guidelines? Cancer Causes Control. 2021 Sep; 32(9):943-951.
-
United we win: Pushing for follow up after a positive faecal immunochemical test. Dig Liver Dis. 2021 08; 53(8):1058.
-
The Performance of Colorectal Cancer Screening in Brazil: The First Two Years of the Implementation Program in Barretos Cancer Hospital. Cancer Prev Res (Phila). 2021 02; 14(2):241-252.
-
Interval colorectal cancers after negative faecal immunochemical test in a 13-year screening programme. J Med Screen. 2021 06; 28(2):131-139.
-
Stable prevalence of faecal immunochemical test positivity over time in Italy. J Med Screen. 2020 09; 27(3):168-169.